Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study
Identifieur interne : 000761 ( Istex/Checkpoint ); précédent : 000760; suivant : 000762Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study
Auteurs : Jang-Jaer Lee [Taïwan] ; Shih-Jung Cheng [Taïwan] ; Jai-Jen Wang [Taïwan] ; Chun-Pin Chiang [Taïwan] ; Hao-Hueng Chang [Taïwan] ; Hsin-Ming Chen [Taïwan] ; Sang-Heng Kok [Taïwan]Source :
- Head & Neck [ 1043-3074 ] ; 2013-12.
Descripteurs français
- Wicri :
- topic : Chiffre d'affaires.
English descriptors
- KwdEn :
- Adjunctive therapy, Alcohol drinking, Alendronate, Alendronate therapy, Alkaline phosphatase, American association, Anterior lesion length, Anterior lesions, Better prognosis, Biochemical markers, Bisphosphonate, Bisphosphonate treatment, Bisphosphonaterelated osteonecrosis, Bisphosphonates, Bone destruction area, Bone formation, Bone mineral density, Bone necrosis, Bone resorption, Bone turnover, Bronj, Bronj diagnosis, Bronj lesions, Bronj patients, Bsap, Bsap level, Bsap levels, Cancer chemotherapy, Cancer patients, Certain period, Chlorhexidine mouth rinse, Clinical factors, Clinical variables, Complete response, Confidence interval, Cumulative dose, December, Deeper extension, Diabetes mellitus, Disease stage, Drug holiday, Drug therapy, Drug treatment, Event dentoalveolar surgery, Hazard ratio, Head december, Head neck, Healing period, Healing time, Higher pretreatment level, Intravenous bisphosphonates, Lesion, Lesion depth, Lesion length, Lesion resolution, Lesion site lesion depth, Lesion site maxilla mandible lesion site, Mandible, Maxillofac, Maxillofacial surgeons, Maxillofacial surgery, Median, Medical comorbidities, Multivariate analyses, Multivariate analysis, National taiwan university, National taiwan university hospital, Oral alendronate, Oral bisphosphonate, Oral bisphosphonate therapy, Oral bisphosphonates, Oral maxillofac surg, Oral oncol, Oral pathol, Oral surg, Osteonecrosis, Osteoporosis, Osteoporotic, Osteoporotic patients, Parathyroid hormone, Pathologic fracture, Pearson correlation coefficient, Phosphatase, Postmenopausal osteoporosis, Postmenopausal women, Present study, Pretreatment, Pretreatment serum bsap, Previous studies, Prognosis, Prognostic, Prognostic figure, Prognostic indicators, Prognostic values, Radiol endod, Risk factors, Serum bsap, Serum bsap level, Serum level, Serum markers, Significant difference, Surg, Surgical, Surgical therapy, Surgical treatment, Teriparatide, Treatment modalities, Treatment outcome, Treatment outcomes, Treatment period, True extent, Turnover, Uninvolved bone.
- Teeft :
- Adjunctive therapy, Alcohol drinking, Alendronate, Alendronate therapy, Alkaline phosphatase, American association, Anterior lesion length, Anterior lesions, Better prognosis, Biochemical markers, Bisphosphonate, Bisphosphonate treatment, Bisphosphonaterelated osteonecrosis, Bisphosphonates, Bone destruction area, Bone formation, Bone mineral density, Bone necrosis, Bone resorption, Bone turnover, Bronj, Bronj diagnosis, Bronj lesions, Bronj patients, Bsap, Bsap level, Bsap levels, Cancer chemotherapy, Cancer patients, Certain period, Chlorhexidine mouth rinse, Clinical factors, Clinical variables, Complete response, Confidence interval, Cumulative dose, December, Deeper extension, Diabetes mellitus, Disease stage, Drug holiday, Drug therapy, Drug treatment, Event dentoalveolar surgery, Hazard ratio, Head december, Head neck, Healing period, Healing time, Higher pretreatment level, Intravenous bisphosphonates, Lesion, Lesion depth, Lesion length, Lesion resolution, Lesion site lesion depth, Lesion site maxilla mandible lesion site, Mandible, Maxillofac, Maxillofacial surgeons, Maxillofacial surgery, Median, Medical comorbidities, Multivariate analyses, Multivariate analysis, National taiwan university, National taiwan university hospital, Oral alendronate, Oral bisphosphonate, Oral bisphosphonate therapy, Oral bisphosphonates, Oral maxillofac surg, Oral oncol, Oral pathol, Oral surg, Osteonecrosis, Osteoporosis, Osteoporotic, Osteoporotic patients, Parathyroid hormone, Pathologic fracture, Pearson correlation coefficient, Phosphatase, Postmenopausal osteoporosis, Postmenopausal women, Present study, Pretreatment, Pretreatment serum bsap, Previous studies, Prognosis, Prognostic, Prognostic figure, Prognostic indicators, Prognostic values, Radiol endod, Risk factors, Serum bsap, Serum bsap level, Serum level, Serum markers, Significant difference, Surg, Surgical, Surgical therapy, Surgical treatment, Teriparatide, Treatment modalities, Treatment outcome, Treatment outcomes, Treatment period, True extent, Turnover, Uninvolved bone.
Abstract
Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.
Url:
DOI: 10.1002/hed.23235
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title>
<author><name sortKey="Lee, Jang Aer" sort="Lee, Jang Aer" uniqKey="Lee J" first="Jang-Jaer" last="Lee">Jang-Jaer Lee</name>
</author>
<author><name sortKey="Cheng, Shih Ung" sort="Cheng, Shih Ung" uniqKey="Cheng S" first="Shih-Jung" last="Cheng">Shih-Jung Cheng</name>
</author>
<author><name sortKey="Wang, Jai En" sort="Wang, Jai En" uniqKey="Wang J" first="Jai-Jen" last="Wang">Jai-Jen Wang</name>
</author>
<author><name sortKey="Chiang, Chun In" sort="Chiang, Chun In" uniqKey="Chiang C" first="Chun-Pin" last="Chiang">Chun-Pin Chiang</name>
</author>
<author><name sortKey="Chang, Hao Ueng" sort="Chang, Hao Ueng" uniqKey="Chang H" first="Hao-Hueng" last="Chang">Hao-Hueng Chang</name>
</author>
<author><name sortKey="Chen, Hsin Ing" sort="Chen, Hsin Ing" uniqKey="Chen H" first="Hsin-Ming" last="Chen">Hsin-Ming Chen</name>
</author>
<author><name sortKey="Kok, Sang Eng" sort="Kok, Sang Eng" uniqKey="Kok S" first="Sang-Heng" last="Kok">Sang-Heng Kok</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96E</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1002/hed.23235</idno>
<idno type="url">https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">006086</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006086</idno>
<idno type="wicri:Area/Istex/Curation">006086</idno>
<idno type="wicri:Area/Istex/Checkpoint">000761</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000761</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study</title>
<author><name sortKey="Lee, Jang Aer" sort="Lee, Jang Aer" uniqKey="Lee J" first="Jang-Jaer" last="Lee">Jang-Jaer Lee</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>School of Dentistry, National Taiwan University Medical Center, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cheng, Shih Ung" sort="Cheng, Shih Ung" uniqKey="Cheng S" first="Shih-Jung" last="Cheng">Shih-Jung Cheng</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>School of Dentistry, National Taiwan University Medical Center, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Jai En" sort="Wang, Jai En" uniqKey="Wang J" first="Jai-Jen" last="Wang">Jai-Jen Wang</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Department of Finance, Feng Chia University, Taichung</wicri:regionArea>
<wicri:noRegion>Taichung</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chiang, Chun In" sort="Chiang, Chun In" uniqKey="Chiang C" first="Chun-Pin" last="Chiang">Chun-Pin Chiang</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Graduate Institute of Oral Biology, School of Dentistry, National Taiwan University Medical Center, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chang, Hao Ueng" sort="Chang, Hao Ueng" uniqKey="Chang H" first="Hao-Hueng" last="Chang">Hao-Hueng Chang</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>School of Dentistry, National Taiwan University Medical Center, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chen, Hsin Ing" sort="Chen, Hsin Ing" uniqKey="Chen H" first="Hsin-Ming" last="Chen">Hsin-Ming Chen</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>School of Dentistry, National Taiwan University Medical Center, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kok, Sang Eng" sort="Kok, Sang Eng" uniqKey="Kok S" first="Sang-Heng" last="Kok">Sang-Heng Kok</name>
<affiliation wicri:level="1"><country xml:lang="fr">Taïwan</country>
<wicri:regionArea>School of Dentistry, National Taiwan University Medical Center, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Taïwan</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Head & Neck</title>
<title level="j" type="alt">HEAD AND NECK</title>
<idno type="ISSN">1043-3074</idno>
<idno type="eISSN">1097-0347</idno>
<imprint><biblScope unit="vol">35</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1787">1787</biblScope>
<biblScope unit="page" to="1795">1795</biblScope>
<biblScope unit="page-count">9</biblScope>
<date type="published" when="2013-12">2013-12</date>
</imprint>
<idno type="ISSN">1043-3074</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1043-3074</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adjunctive therapy</term>
<term>Alcohol drinking</term>
<term>Alendronate</term>
<term>Alendronate therapy</term>
<term>Alkaline phosphatase</term>
<term>American association</term>
<term>Anterior lesion length</term>
<term>Anterior lesions</term>
<term>Better prognosis</term>
<term>Biochemical markers</term>
<term>Bisphosphonate</term>
<term>Bisphosphonate treatment</term>
<term>Bisphosphonaterelated osteonecrosis</term>
<term>Bisphosphonates</term>
<term>Bone destruction area</term>
<term>Bone formation</term>
<term>Bone mineral density</term>
<term>Bone necrosis</term>
<term>Bone resorption</term>
<term>Bone turnover</term>
<term>Bronj</term>
<term>Bronj diagnosis</term>
<term>Bronj lesions</term>
<term>Bronj patients</term>
<term>Bsap</term>
<term>Bsap level</term>
<term>Bsap levels</term>
<term>Cancer chemotherapy</term>
<term>Cancer patients</term>
<term>Certain period</term>
<term>Chlorhexidine mouth rinse</term>
<term>Clinical factors</term>
<term>Clinical variables</term>
<term>Complete response</term>
<term>Confidence interval</term>
<term>Cumulative dose</term>
<term>December</term>
<term>Deeper extension</term>
<term>Diabetes mellitus</term>
<term>Disease stage</term>
<term>Drug holiday</term>
<term>Drug therapy</term>
<term>Drug treatment</term>
<term>Event dentoalveolar surgery</term>
<term>Hazard ratio</term>
<term>Head december</term>
<term>Head neck</term>
<term>Healing period</term>
<term>Healing time</term>
<term>Higher pretreatment level</term>
<term>Intravenous bisphosphonates</term>
<term>Lesion</term>
<term>Lesion depth</term>
<term>Lesion length</term>
<term>Lesion resolution</term>
<term>Lesion site lesion depth</term>
<term>Lesion site maxilla mandible lesion site</term>
<term>Mandible</term>
<term>Maxillofac</term>
<term>Maxillofacial surgeons</term>
<term>Maxillofacial surgery</term>
<term>Median</term>
<term>Medical comorbidities</term>
<term>Multivariate analyses</term>
<term>Multivariate analysis</term>
<term>National taiwan university</term>
<term>National taiwan university hospital</term>
<term>Oral alendronate</term>
<term>Oral bisphosphonate</term>
<term>Oral bisphosphonate therapy</term>
<term>Oral bisphosphonates</term>
<term>Oral maxillofac surg</term>
<term>Oral oncol</term>
<term>Oral pathol</term>
<term>Oral surg</term>
<term>Osteonecrosis</term>
<term>Osteoporosis</term>
<term>Osteoporotic</term>
<term>Osteoporotic patients</term>
<term>Parathyroid hormone</term>
<term>Pathologic fracture</term>
<term>Pearson correlation coefficient</term>
<term>Phosphatase</term>
<term>Postmenopausal osteoporosis</term>
<term>Postmenopausal women</term>
<term>Present study</term>
<term>Pretreatment</term>
<term>Pretreatment serum bsap</term>
<term>Previous studies</term>
<term>Prognosis</term>
<term>Prognostic</term>
<term>Prognostic figure</term>
<term>Prognostic indicators</term>
<term>Prognostic values</term>
<term>Radiol endod</term>
<term>Risk factors</term>
<term>Serum bsap</term>
<term>Serum bsap level</term>
<term>Serum level</term>
<term>Serum markers</term>
<term>Significant difference</term>
<term>Surg</term>
<term>Surgical</term>
<term>Surgical therapy</term>
<term>Surgical treatment</term>
<term>Teriparatide</term>
<term>Treatment modalities</term>
<term>Treatment outcome</term>
<term>Treatment outcomes</term>
<term>Treatment period</term>
<term>True extent</term>
<term>Turnover</term>
<term>Uninvolved bone</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Adjunctive therapy</term>
<term>Alcohol drinking</term>
<term>Alendronate</term>
<term>Alendronate therapy</term>
<term>Alkaline phosphatase</term>
<term>American association</term>
<term>Anterior lesion length</term>
<term>Anterior lesions</term>
<term>Better prognosis</term>
<term>Biochemical markers</term>
<term>Bisphosphonate</term>
<term>Bisphosphonate treatment</term>
<term>Bisphosphonaterelated osteonecrosis</term>
<term>Bisphosphonates</term>
<term>Bone destruction area</term>
<term>Bone formation</term>
<term>Bone mineral density</term>
<term>Bone necrosis</term>
<term>Bone resorption</term>
<term>Bone turnover</term>
<term>Bronj</term>
<term>Bronj diagnosis</term>
<term>Bronj lesions</term>
<term>Bronj patients</term>
<term>Bsap</term>
<term>Bsap level</term>
<term>Bsap levels</term>
<term>Cancer chemotherapy</term>
<term>Cancer patients</term>
<term>Certain period</term>
<term>Chlorhexidine mouth rinse</term>
<term>Clinical factors</term>
<term>Clinical variables</term>
<term>Complete response</term>
<term>Confidence interval</term>
<term>Cumulative dose</term>
<term>December</term>
<term>Deeper extension</term>
<term>Diabetes mellitus</term>
<term>Disease stage</term>
<term>Drug holiday</term>
<term>Drug therapy</term>
<term>Drug treatment</term>
<term>Event dentoalveolar surgery</term>
<term>Hazard ratio</term>
<term>Head december</term>
<term>Head neck</term>
<term>Healing period</term>
<term>Healing time</term>
<term>Higher pretreatment level</term>
<term>Intravenous bisphosphonates</term>
<term>Lesion</term>
<term>Lesion depth</term>
<term>Lesion length</term>
<term>Lesion resolution</term>
<term>Lesion site lesion depth</term>
<term>Lesion site maxilla mandible lesion site</term>
<term>Mandible</term>
<term>Maxillofac</term>
<term>Maxillofacial surgeons</term>
<term>Maxillofacial surgery</term>
<term>Median</term>
<term>Medical comorbidities</term>
<term>Multivariate analyses</term>
<term>Multivariate analysis</term>
<term>National taiwan university</term>
<term>National taiwan university hospital</term>
<term>Oral alendronate</term>
<term>Oral bisphosphonate</term>
<term>Oral bisphosphonate therapy</term>
<term>Oral bisphosphonates</term>
<term>Oral maxillofac surg</term>
<term>Oral oncol</term>
<term>Oral pathol</term>
<term>Oral surg</term>
<term>Osteonecrosis</term>
<term>Osteoporosis</term>
<term>Osteoporotic</term>
<term>Osteoporotic patients</term>
<term>Parathyroid hormone</term>
<term>Pathologic fracture</term>
<term>Pearson correlation coefficient</term>
<term>Phosphatase</term>
<term>Postmenopausal osteoporosis</term>
<term>Postmenopausal women</term>
<term>Present study</term>
<term>Pretreatment</term>
<term>Pretreatment serum bsap</term>
<term>Previous studies</term>
<term>Prognosis</term>
<term>Prognostic</term>
<term>Prognostic figure</term>
<term>Prognostic indicators</term>
<term>Prognostic values</term>
<term>Radiol endod</term>
<term>Risk factors</term>
<term>Serum bsap</term>
<term>Serum bsap level</term>
<term>Serum level</term>
<term>Serum markers</term>
<term>Significant difference</term>
<term>Surg</term>
<term>Surgical</term>
<term>Surgical therapy</term>
<term>Surgical treatment</term>
<term>Teriparatide</term>
<term>Treatment modalities</term>
<term>Treatment outcome</term>
<term>Treatment outcomes</term>
<term>Treatment period</term>
<term>True extent</term>
<term>Turnover</term>
<term>Uninvolved bone</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Chiffre d'affaires</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract">Studies concerning prognostic factors specific for alendronate‐related osteonecrosis of the jaws (ONJ) are rare.</div>
</front>
</TEI>
<affiliations><list><country><li>Taïwan</li>
</country>
</list>
<tree><country name="Taïwan"><noRegion><name sortKey="Lee, Jang Aer" sort="Lee, Jang Aer" uniqKey="Lee J" first="Jang-Jaer" last="Lee">Jang-Jaer Lee</name>
</noRegion>
<name sortKey="Chang, Hao Ueng" sort="Chang, Hao Ueng" uniqKey="Chang H" first="Hao-Hueng" last="Chang">Hao-Hueng Chang</name>
<name sortKey="Chen, Hsin Ing" sort="Chen, Hsin Ing" uniqKey="Chen H" first="Hsin-Ming" last="Chen">Hsin-Ming Chen</name>
<name sortKey="Cheng, Shih Ung" sort="Cheng, Shih Ung" uniqKey="Cheng S" first="Shih-Jung" last="Cheng">Shih-Jung Cheng</name>
<name sortKey="Chiang, Chun In" sort="Chiang, Chun In" uniqKey="Chiang C" first="Chun-Pin" last="Chiang">Chun-Pin Chiang</name>
<name sortKey="Kok, Sang Eng" sort="Kok, Sang Eng" uniqKey="Kok S" first="Sang-Heng" last="Kok">Sang-Heng Kok</name>
<name sortKey="Kok, Sang Eng" sort="Kok, Sang Eng" uniqKey="Kok S" first="Sang-Heng" last="Kok">Sang-Heng Kok</name>
<name sortKey="Wang, Jai En" sort="Wang, Jai En" uniqKey="Wang J" first="Jai-Jen" last="Wang">Jai-Jen Wang</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000761 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 000761 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96E |texte= Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study }}
This area was generated with Dilib version V0.6.32. |